+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Microbial Testing Market by Product (Instruments, Reagents), Application (Chemical & Material Manufacturing, Clinical, Energy), End-User - Forecast 2023-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968643
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Microbial Testing Market size was estimated at USD 3.30 billion in 2022, USD 3.76 billion in 2023, and is expected to grow at a CAGR of 14.68% to reach USD 9.90 billion by 2030.

Microbiology testing is an analytical technique used to determine the microorganisms in numerous samples such as biological, food & beverage, and environmental samples. Microbiology testing uses chemical, biological, molecular, and biochemical methods and is applied to disease-causing and spoilage microorganisms. As per World Health Organization (WHO), around 7 million people get infected by influenza in the United States every year, creating a huge scope of growth for research and development proficiencies associated with microbiology testing. Several new government policies in enhancing the diagnostic and testing processes led to the growth of microbiology testing, as it is an essential component in testing viruses. However, concerns related to microbial testing instruments recall and the shortage of skilled workforce significantly impedes the utilization of microbial testing. In addition, emerging technological advancements in microbial testing technologies and improved medical infrastructures in hospitals and clinical labs are expected to create robust opportunities for developing the microbial testing market. Several newly developed molecular diagnostic methods such as real-time PCR, NGS, molecular cartridges, and PCR combined with mass spectrometry are employed for early identification and efficient treatment of pathogen-borne disorders and to analyze multiple samples in a single run.

Regional Insights

In North America, huge healthcare facilities, increasing investment from major market players in the growth of advanced devices, well-established distribution channels for clinical microbiology product manufacturers, and a growing number of research activities boost the utilization of microbial testing methods. According to the National Institutes of Health (NIH), in May 2022, the funding for antimicrobial resistance research increased from USD 656 million in 2021 to USD 665 million in 2022. Such increasing investment in research by the government is propelling the growth of the microbiology testing market in the region. The rising government initiatives to raise awareness and favorable regulatory policies to increase the adoption rate for microbiology testing and the higher demand for quality healthcare facilities in the Asia-Pacific region enhance the adoption of microbial testing for various applications. In May 2022, Merck India established a Microbial Application Training lab (MATLab) in Bangalore for academic and commercial objectives. The lab invites Merck and other pharma and biopharma companies to work together to build up their skills for microbial investigation. The microbiological testing market is developing in Europe owing to technological developments, increasing infectious illnesses and epidemic outbreaks, rising healthcare costs, and expanding private-public support for infectious disease research. The rapidly growing geriatric population, growth in clinical research studies in clinical microbiology, and increasing funding, research grants, and investments are key factors influencing microbiology testing across Europe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Microbial Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Microbial Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Microbial Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Accepta Ltd., AEMTEK Laboratories, Agilent Technologies, Inc., ALS Limited, ARL Bio Pharma, Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMérieux SA, Biosan Laboratories, Inc., Bruker Corporation, Charles River Laboratories, Döhler GmbH, Ecolyse, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Intertek Group PLC, LuminUltra Technologies Ltd., Medicinal Genomics Corp., Merck KGaA, Microbac Laboratories Inc., Nelson Laboratories, LLC, NEOGEN Corporation, QIAGEN N.V., Sartorius AG, SGS S.A., Shimazdu Corporation, Thermo Fisher Scientific Inc., and TÜV SÜD.

Market Segmentation & Coverage

This research report categorizes the Microbial Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Reagents
  • Application
    • Chemical & Material Manufacturing
    • Clinical
      • Bloodstream Infections
      • Gastrointestinal Diseases
      • Periodontal Diseases
      • Respiratory Diseases
      • Sexually Transmitted Diseases
      • Urinary Tract Infections
    • Energy
    • Environment
    • Food Testing
    • Pharmaceutical
  • End-User
    • Academic & Research Institutes
    • Hospitals & Diagnostic Centers
    • Lab Service Providers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Microbial Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Microbial Testing Market?
  3. What are the technology trends and regulatory frameworks in the Microbial Testing Market?
  4. What is the market share of the leading vendors in the Microbial Testing Market?
  5. Which modes and strategic moves are suitable for entering the Microbial Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Microbial Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of various infectious diseases
5.1.1.2. Surge in pharmaceutical research and focus on microbiological quality control
5.1.1.3. Rising safety standards for food and cosmetic products
5.1.2. Restraints
5.1.2.1. Concerns related to the recall of microbial testing instruments
5.1.3. Opportunities
5.1.3.1. Growing advancements in microbial testing technologies
5.1.3.2. Growing importance of microbiological evaluation of feed ingredients and finished feeds
5.1.4. Challenges
5.1.4.1. Shortage of skilled workforce and the high cost associated with the processes
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.3.1. Availability of funding with the increasing development of technologically advanced microbial testing in the Americas
5.3.2. Rising prevalence of food infection and infectious diseases with increasing awareness to adopt tested and assured food and pharmaceutical products in Asia-Pacific region
5.3.3. Strict regulatory standards for food safety coupled with the rising expansion of the pharmaceutical industry in the EMEA region
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
6. Microbial Testing Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents
7. Microbial Testing Market, by Application
7.1. Introduction
7.2. Chemical & Material Manufacturing
7.3. Clinical
7.4.1. Bloodstream Infections
7.4.2. Gastrointestinal Diseases
7.4.3. Periodontal Diseases
7.4.4. Respiratory Diseases
7.4.5. Sexually Transmitted Diseases
7.4.6. Urinary Tract Infections
7.4. Energy
7.5. Environment
7.6. Food Testing
7.7. Pharmaceutical
8. Microbial Testing Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals & Diagnostic Centers
8.4. Lab Service Providers
9. Americas Microbial Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Microbial Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Microbial Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Thermo Fisher Scientific Inc. - Thermo Fisher Scientific Completed Acquisition of The Binding Site Group
12.3.1.2. Acquisition Expanded Water Microbiology Testing Capabilities Labmate Online
12.3.1.3. SGS Acquired Industry Lab in Romania
12.3.1.4. NAMSA Acquires UK-Based Perfectus Biomed Group to Enhance Customized Microbiological Solutions
12.3.1.5. Bio-Rad buys Curiosity Diagnostics for up to USD 170 million
12.3.1.6. BioMérieux Acquired Antibiotic Susceptibility Test Firm Specific Diagnostics
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Nemera and Nelson Labs Europe strengthened partnership to offer integrated services to customer
12.3.2.2. Beckman Coulter and MeMed to Expanded Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
12.3.2.3. AstraZeneca Partnered with LBT to automate pharma microbial QC
12.3.2.4. FASTinov collaborated with Beckman Coulter Life Sciences to bring ultra-rapid 2h-AST disruptive technology to clinical microbiology laboratories
12.3.2.5. Medical Genomics and UgenTec partnered to automate cannabis testing results, minimizing labor and inconsistencies
12.3.2.6. BD, Accelerate Diagnostics Announced Global Commercial Collaboration
12.3.2.7. bioMérieux Collaborated with FSSAI to Celebrate World Food Safety Day 2022
12.3.3. New Product Launch & Enhancement
12.3.3.1. Bruker Introduced New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper, and a Novel LiquidArray Gastrointestinal Syndromic Panel
12.3.3.2. MicroVal Approved Bio-Rad PCR Kit for Detection of STEC in Flour and Raw Dough
12.3.3.3. Hardy Diagnostics Launched New Ready-To-Use Dehydrated Culture Plate
12.3.3.4. Charles River launched Endosafe Nexus 200
12.3.3.5. LuminUltra launched latest molecular diagnostic innovation with the GeneCount Corrosion Collection
12.3.3.6. Thermo Fisher introduced new gastrointestinal bacteria detection panel
12.3.3.7. Microgenetics developed rapid microbial test method with six-hour result time
12.3.3.8. MilliporeSigma Launched Culture Media System For Microbiological Food Testing
12.3.3.9. Thermo Fisher Scientific launched rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens
12.3.3.10. BD Introduced Smart Connected Robotics to Automate Microbial Identification
12.3.4. Investment & Funding
12.3.4.1. MilliporeSigma Invested USD 286 Million in U.S. Drug Safety Testing Capacity
12.3.4.2. MSU researcher received USD 769K grant to develop rapid test for foodborne pathogens - Department of Biosystems & Agricultural Engineering
12.3.4.3. Biolog Announced New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products
12.3.4.4. EUR 22 million EU (USD 23.21) backing for Israeli microbiology diagnostic leader Pocared
12.3.5. Award, Recognition, & Expansion
12.3.5.1. Nelson Labs receives ASCA accreditation from FDA
12.3.5.2. SGS’s New Agri-Commodity and Food Testing Laboratory in Brazil Received ISO 17025 and AOAC International Accreditation
12.3.5.3. Roche received US FDA Emergency Use Authorization for its high-throughput automated test to detect monkeypox virus
12.3.5.4. ADM opened N. America microbiology lab
12.3.5.5. Solvay opened a new microbiology lab for the energy sector in the UK
12.3.5.6. PerkinElmer Expands Food Safety Testing Portfolio with AOAC Certified Microbial Count Plates
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Abbott Laboratories
13.1.3. Accepta Ltd.
13.1.4. AEMTEK Laboratories
13.1.5. Agilent Technologies, Inc.
13.1.6. ALS Limited
13.1.7. ARL Bio Pharma, Inc.
13.1.8. Beckman Coulter Inc.
13.1.9. Becton, Dickinson and Company
13.1.10. Bio-Rad Laboratories Inc.
13.1.11. bioMérieux SA
13.1.12. Biosan Laboratories, Inc.
13.1.13. Bruker Corporation
13.1.14. Charles River Laboratories
13.1.15. Döhler GmbH
13.1.16. Ecolyse, Inc.
13.1.17. Eurofins Scientific SE
13.1.18. F. Hoffmann-La Roche Ltd.
13.1.19. Intertek Group PLC
13.1.20. LuminUltra Technologies Ltd.
13.1.21. Medicinal Genomics Corp.
13.1.22. Merck KGaA
13.1.23. Microbac Laboratories Inc.
13.1.24. Nelson Laboratories, LLC
13.1.25. NEOGEN Corporation
13.1.26. QIAGEN N.V.
13.1.27. Sartorius AG
13.1.28. SGS S.A.
13.1.29. Shimazdu Corporation
13.1.30. Thermo Fisher Scientific Inc.
13.1.31. TÜV SÜD
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. MICROBIAL TESTING MARKET RESEARCH PROCESS
FIGURE 2. MICROBIAL TESTING MARKET SIZE, 2022 VS 2030
FIGURE 3. MICROBIAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MICROBIAL TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MICROBIAL TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MICROBIAL TESTING MARKET DYNAMICS
FIGURE 7. MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. MICROBIAL TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 12. MICROBIAL TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. MICROBIAL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. MICROBIAL TESTING MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. MICROBIAL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. MICROBIAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MICROBIAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. MICROBIAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MICROBIAL TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. MICROBIAL TESTING MARKET SIZE, BY CHEMICAL & MATERIAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MICROBIAL TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 12. MICROBIAL TESTING MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MICROBIAL TESTING MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MICROBIAL TESTING MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. MICROBIAL TESTING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. MICROBIAL TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. MICROBIAL TESTING MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MICROBIAL TESTING MARKET SIZE, BY ENERGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. MICROBIAL TESTING MARKET SIZE, BY ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. MICROBIAL TESTING MARKET SIZE, BY FOOD TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. MICROBIAL TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. MICROBIAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. MICROBIAL TESTING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. MICROBIAL TESTING MARKET SIZE, BY LAB SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CANADA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 42. CANADA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. MEXICO MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. MEXICO MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 46. MEXICO MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES MICROBIAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. CHINA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CHINA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. CHINA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 64. CHINA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. INDIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 68. INDIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. JAPAN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. JAPAN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. JAPAN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 76. JAPAN MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. THAILAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. THAILAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. THAILAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 100. THAILAND MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA MICROBIAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. DENMARK MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 113. DENMARK MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EGYPT MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. EGYPT MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. EGYPT MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 117. EGYPT MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FINLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FINLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. FINLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 121. FINLAND MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. FRANCE MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. FRANCE MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 125. FRANCE MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. GERMANY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. GERMANY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 129. GERMANY MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. ITALY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ITALY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 137. ITALY MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. NORWAY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. NORWAY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. NORWAY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 149. NORWAY MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. POLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. POLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. POLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 153. POLAND MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. QATAR MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. QATAR MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. QATAR MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 157. QATAR MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SPAIN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SPAIN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 173. SPAIN MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. TURKEY MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. TURKEY MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. TURKEY MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 185. TURKEY MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM MICROBIAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM MICROBIAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM MICROBIAL TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM MICROBIAL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. MICROBIAL TESTING MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 195. MICROBIAL TESTING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 196. MICROBIAL TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Accepta Ltd.
  • AEMTEK Laboratories
  • Agilent Technologies, Inc.
  • ALS Limited
  • ARL Bio Pharma, Inc.
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • bioMérieux SA
  • Biosan Laboratories, Inc.
  • Bruker Corporation
  • Charles River Laboratories
  • Döhler GmbH
  • Ecolyse, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Intertek Group PLC
  • LuminUltra Technologies Ltd.
  • Medicinal Genomics Corp.
  • Merck KGaA
  • Microbac Laboratories Inc.
  • Nelson Laboratories, LLC
  • NEOGEN Corporation
  • QIAGEN N.V.
  • Sartorius AG
  • SGS S.A.
  • Shimazdu Corporation
  • Thermo Fisher Scientific Inc.
  • TÜV SÜD

Methodology

Loading
LOADING...

Table Information